Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced NSCLC × Nivolumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 145 Carcinoma, Non-Small-Cell Lung 110 Carcinoma, Renal Cell 73 Neoplasm Metastasis 52 Carcinoma, Hepatocellular 51 Squamous Cell Carcinoma of Head and Neck 49 Lung Neoplasms 46 Colorectal Neoplasms 32 Pancreatic Neoplasms 30 Neoplasms 30 Hodgkin Disease 28 Urinary Bladder Neoplasms 24 Sarcoma 23 Brain Neoplasms 23 Stomach Neoplasms 21 Head and Neck Neoplasms 21 Breast Neoplasms 21 Prostatic Neoplasms 20 Glioblastoma 19 Carcinoma, Transitional Cell 19 Recurrence 17 Colonic Neoplasms 17 Kidney Neoplasms 16 Uveal Melanoma 15 Small Cell Lung Carcinoma 15 Multiple Myeloma 15 Esophageal Neoplasms 15 Carcinoma, Squamous Cell 14 Skin Neoplasms 13 Leukemia, Myeloid, Acute 13

Interventions

Radiotherapy 4 Immune Checkpoint Inhibitors 4 Oxaliplatin 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04043195 2025-05-28

NSCLC

University of California, San Diego

Phase 1/2 Active not recruiting

Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡